CTOs on the Move

Rechargeable Battery Recycling Corp

www.rbrc.org

 
Rechargeable Battery Recycling Corp is a Atlanta, GA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.rbrc.org
  • 1000 Parkwood Cir SE Ste 450
    Atlanta, GA USA 30339
  • Phone: 678.419.9990

Executives

Name Title Contact Details

Similar Companies

The Ford Meter Box Company

The Ford Meter Box Company, Inc. is a Wabash, IN-based company in the Business Services sector.

Sims Lifecycle Services

Sims Lifecycle Services (SLS) specializes in providing resourceful solutions to manage different streams for retired electronic equipment, components and metals. SLS plays a key role in helping local, national and global companies manage ongoing technology shifts by securely and responsibly recycling electronic products, managing the disposition of IT equipment and providing data center decommissioning services. SLS works with businesses and major cloud companies to provide periodic decommissioning of older data center equipment, as well as with companies that are closing down their corporate data centers as work moves to the cloud. The IT asset disposition (ITAD) and electronics recycling services offered at SLS ensure clients of data security, brand protection and maximum IT value recovery, while optimizing material reuse and supporting the circular economy. As a responsible corporate citizen, we continuously seek new ways to broaden our participation in the environmental sector. For more information, visit www.simslifecycle.com.

M Hart Express Inc

M Hart Express Inc is a Hope, IN-based company in the Business Services sector.

Programming Resources Inc

Programming Resources Inc is a Nashville, TN-based company in the Business Services sector.

DRI Healthcare

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Over the course of three decades, we have been a trusted partner of royalty sellers and demonstrated strong execution, building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. That foundation sets us apart as we continue developing solutions for innovators while building and managing a risk-mitigated portfolio of therapeutic assets that generates attractive returns and growth potential for investors. We have deployed more than $2.5 billion, acquiring more than 70 royalties on 40-plus drugs.